Using Bax/Bak knockout AML cells as well as caspase inhibitors and blocking antibodies, we demonstrate that, mechanistically, the extrinsic pathway is not a significant contributor to this combinatorial efficacy. The gene discussed is BAK1; the disease is acute myeloid leukemia.